rpoB gene mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis in Northern Lima, Peru

Microbial Drug Resistance

Volumn 11, Issue 1, 2005, Pages 26-30

  Shin, Sonya S ^a,b,c   Naroditskaya, V ^d   Sloutsky, A ^d   Werner, B ^d   Timperi, R ^d   Bayona, J ^b,c   Farmer, P E ^a,b,c   Becerra, M C ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Socios Salud Suc Peru/Ptnrs Hlth   (Peru)

^d Massachusetts State Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DEVELOPING COUNTRY; DNA SEQUENCE; ENDEMIC DISEASE; GENE MUTATION; MULTIDRUG RESISTANCE; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT REFERRAL; PERU; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTIBIOTICS, ANTITUBERCULAR; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MICROBIAL; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PERU; RIFAMPIN; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, PULMONARY;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 14944349541     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.26     Document Type: Article

References (30)

1. Becerra, M.C., J. Freeman, J. Bayona, et al. 2000. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 4:108-114.
2. Beenhouwer, H., Z. Lhiang, G. Jannes, W. Mijs, L. Machtelinckx, R. Rossau, H. Traore, and F. Portaels. 1995. Rapid detection of rifampin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis. 76:425-430.
3. Chaves, F., M. Alonso-Sanz, M.J. Rebollo, J.C. Tercero, M.S. Jimenez, and A.R. Noriega. 2000. rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung. Dis. 4:465-470.
4. Crawford, J.T., C.R. Braden, B.A. Schable, and I.M. Onorato. 2002. National Tuberculosis Genotyping and Surveillance Network: design and methods. Emerg. Infect. Dis. 8:1192-1196.
5. Dye C., S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J. Am. Med. Assn. 282:677-686.
6. Escalante, P., S. Ramaswamy, H. Sanabria, et al. 1998. Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tubercle Lung Dis. 79:111-118.
7. Frieden, T.R., T. Sterling, A. Pablos-Mendez, J.O. Kilburn, G.M. Cauthen, and S.W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.
8. Hawkins, J.E. 1986. Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 23:934-937.
9. Iseman, M. 1993. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med. 329:784-791.
10. Kent, P.T., and G. Kubica. 1985. Public Health Mycobacteriology. A Guide for the Level III Laboratory. Atlanta, GA: DHHS, Centers for Disease Control.
11. Marttila, H.J., H. Soini, B.I. Vyshnevskiy, T.F. Otten, A.V. Vasilyef, P. Huovinen, and M.K. Viljanen. 1998. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand. J. Infect. Dis. 30:129-132.
12. Miller, L., J. Crawford, and T. Shin nick. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
13. Morris, S., G.H. Bai, P. Suffys, L. Portillo-Gomez, M. Fairchok, and D. Rouse. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 171:954-960.
14. Musser, J.M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
15. Patnaik, M., K. Liegmann, and J.B. Peter. 2001. Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides. J. Clin. Microbiol. 39:51-52.
16. Portugal, I., S. Maia, and J. Moniz-Pereira. 1999. Discrimination of multidrug-resistant Mycobacterium tuberculosis 1S6110 fingerprint subclusters by rpoB gene mutation analysis. J. Clin. Microbiol. 37:3022-3024.
17. Quian, L., C. Abe, T. Lin, M. Yu, S. Cho, S. Wang, and J. Douglas. 2002. rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J. Clin. Microbiol. 40:1091-1094.
18. Ramaswamy, S., and J.M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
19. Rattan, A., A. Kalia, and N. Ahmad. 1998. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg. Inf. Dis. 4:195-209.
20. Sintchenko, V., W. Chew, P. Jelfs, and G. Gilbert. 1999. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology 31:257-260.
21. Smithwick, R.W. 1976. Laboratory manual for acid-fast microscopy. Second ed. Atlanta, GA: Centers for Disease Control.
22. Strong, B.E., and G. Kubica. 1981. Isolation and identification of Mycobacterium tuberculosis: A Guide for the Level II Laboratory. Atlanta. GA: Centers for Disease Control.
23. Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H.E. Takiff, and S.T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
24. Telenti, A., P. Imboden, F. Marchesi, T. Schmidheini, and T. Bodmer. 1993. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother. 37:2054-2058.
25. Telenti, A., and D.H. Persing. 1996. Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis. Res. Microbiol. 147:73-79.
26. Turett, G.S., E.E. Telzak, L.V. Torian, S. Blum, D. Alland, I. Weisfuse, and B.A. Fazal. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 21:1238-1244.
27. Van Embden, J., M. Cave, J. Crawford, J. Dale, K. Eisenach, B. Gicquel, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
28. Van Soolingen, D., P.E.W. de Haas, P.W.M. Hermans, and J.D.A. van Embden. 1994. DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol. 235:196-205.
29. Van Soolingen, D., P.W. Hermans, P.E. de Haas, D.R. Soll, and J.D. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
30. Williams, D.L., L. Spring, L. Collins, L.P. Miller, L.B. Heifets, P.R. Gangadharam, and T.P. Gillis. 1998. Contributions of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42: 1853-1857.